This statistic shows the number of biosimilars in development and approved by the FDA for hematology, inflammation and immunology, and oncology therapeutic areas in the U.S. as of May 2019, by manufacturer. At that moment, drug manufacturer Apobiologix (Apotex) had seven biosimilars in development for these areas.
Biosimilars in development and approved by the FDA as of May 2019, by manufacturer
(for selected therapeutic areas)
Includes biosimilars for hematology, inflammation and immunology, and oncology and may not be all-inclusive.
* Includes biosimilars in Preclinical, Phase 1, Phase 2, Phase 3, or submitted to FDA. Totals based on publicly available information. Additional biosimilars could be in preclinical or phase 1 development and not yet reported publicly.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (May 30, 2019). Biosimilars in development and approved by the FDA as of May 2019, by manufacturer (for selected therapeutic areas) [Graph]. In Statista. Retrieved October 02, 2024, from https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/
Amgen. "Biosimilars in development and approved by the FDA as of May 2019, by manufacturer (for selected therapeutic areas)." Chart. May 30, 2019. Statista. Accessed October 02, 2024. https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/
Amgen. (2019). Biosimilars in development and approved by the FDA as of May 2019, by manufacturer (for selected therapeutic areas). Statista. Statista Inc.. Accessed: October 02, 2024. https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/
Amgen. "Biosimilars in Development and Approved by The Fda as of May 2019, by Manufacturer (for Selected Therapeutic Areas)." Statista, Statista Inc., 30 May 2019, https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/
Amgen, Biosimilars in development and approved by the FDA as of May 2019, by manufacturer (for selected therapeutic areas) Statista, https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/ (last visited October 02, 2024)
Biosimilars in development and approved by the FDA as of May 2019, by manufacturer (for selected therapeutic areas) [Graph], Amgen, May 30, 2019. [Online]. Available: https://www.statista.com/statistics/1088388/biosimilars-in-development-and-approved-by-fda-by-manufacturer/